Search alternatives:
significantly largest » significantly larger (Expand Search), significantly less (Expand Search), significantly affect (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
smaller decrease » marked decrease (Expand Search), smaller areas (Expand Search), larger decrease (Expand Search)
small decrease » small increased (Expand Search)
Showing 261 - 280 results of 1,777 for search '(( significantly largest decrease ) OR ( significantly ((smaller decrease) OR (small decrease)) ))', query time: 0.30s Refine Results
  1. 261
    Effect of miR-1247-3p on survival in colorectal cancer patients.

    Effect of miR-1247-3p on survival in colorectal cancer patients. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 262
    Mod antibody and RNAi validations.

    Mod antibody and RNAi validations. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 263
    Mod is required to maintain nucleolar architecture.

    Mod is required to maintain nucleolar architecture. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 264
    Differential gene expression analysis following Mod knockdown.

    Differential gene expression analysis following Mod knockdown. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 265
    S1 Raw images -

    S1 Raw images - by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 266
    Mod loss is associated with a reduction of central brain NBs.

    Mod loss is associated with a reduction of central brain NBs. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 267
    Introduction to the dataset.

    Introduction to the dataset. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 268
    RNA targets and biological process GO terms associated with Mod RiP-Seq analysis.

    RNA targets and biological process GO terms associated with Mod RiP-Seq analysis. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 269
    Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells.

    Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 270
    Mod localizes both within and outside the nucleolus in NBs.

    Mod localizes both within and outside the nucleolus in NBs. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 271
    miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance.

    miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 272
    Rethinking the Role of AuNPs in Colorimetric Aptasensors: Dominant Nonspecific Interactions with Antibiotics over Aptamer Recognition

    Rethinking the Role of AuNPs in Colorimetric Aptasensors: Dominant Nonspecific Interactions with Antibiotics over Aptamer Recognition by Zhuoer Chen (22671791)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 273
    Rethinking the Role of AuNPs in Colorimetric Aptasensors: Dominant Nonspecific Interactions with Antibiotics over Aptamer Recognition

    Rethinking the Role of AuNPs in Colorimetric Aptasensors: Dominant Nonspecific Interactions with Antibiotics over Aptamer Recognition by Zhuoer Chen (22671791)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 274
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 275
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 276
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 277
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 278
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 279
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 280
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: